表2.
225例肺腺癌患者实验室检查的单因素分析
| Variables | Total (n=225) | VTE | P | |
|---|---|---|---|---|
| Negative (n=193) | Positive (n=32) | |||
| Thrombelastogram | 0.13 | |||
| Normal | 212 (94.22%) | 180 (93.26%) | 32 (100.00%) | |
| Abnormal | 13 (5.78%) | 13 (6.74%) | 0 (0.00%) | |
| Platelet (×109/L) | 0.74 | |||
| Normal | 207 (92.00%) | 177 (91.71%) | 30 (93.76%) | |
| Higher than normal | 13 (5.78%) | 12 (6.22%) | 1 (3.12%) | |
| Lower than normal | 5 (2.22%) | 4 (2.07%) | 1 (3.12%) | |
| APTT (s) | 0.77 | |||
| Normal | 195 (86.67%) | 166 (86.01%) | 29 (90.63%) | |
| Higher than normal | 20 (8.89%) | 18 (9.33%) | 2 (6.25%) | |
| Lower than normal | 10 (4.44%) | 9 (4.66%) | 1 (3.12%) | |
| PT (s) | 0.41 | |||
| Normal | 221 (98.22%) | 189 (97.93%) | 32 (100.00%) | |
| Abnormal | 4 (1.78%) | 4 (2.07%) | 0 (0.00%) | |
| FIB (g/L) | 0.61 | |||
| Normal | 169 (75.11%) | 147 (76.17%) | 22 (68.75%) | |
| Higher than normal | 47 (20.89%) | 39 (20.21%) | 8 (25.00%) | |
| Lower than normal | 9 (4.00%) | 7 (3.62%) | 2 (6.25%) | |
| PT-INR | 0.68 | |||
| Normal | 224 (99.56%) | 192 (99.48%) | 32 (100.00%) | |
| Abnormal | 1 (0.44%) | 1 (0.52%) | 0 (0.00%) | |
| D-D (mg/L) | 0.44 | |||
| Normal | 127 (56.44%) | 112 (58.03%) | 15 (46.88%) | |
| Abnormal | 98 (43.56%) | 81 (41.97%) | 17 (53.12%) | |
APTT: activated partial thromboplastin time; PT: prothrombin time; FIB: fibrinogen; PT-INR: PT-international normalized ratio; D-D: D-Dimer.